Bouman HJ[au] - Search Results

Year	Number of Results
1979	1
1980	2
2008	3
2009	7
2010	12
2011	11
2012	2
2014	1
2016	1
2017	1
2022	0

1

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.

van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM. van Werkum JW, et al. Among authors: bouman hj. Platelets. 2008 Nov;19(7):479-88. doi: 10.1080/09537100802317918. Platelets. 2008. PMID: 18979359 Review.

2

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM, Taubert D. Bauer T, et al. Among authors: bouman hj. BMJ. 2011 Aug 4;343:d4588. doi: 10.1136/bmj.d4588. BMJ. 2011. PMID: 21816733 Free PMC article. Review.

3

Paraoxonase-1 is a major determinant of clopidogrel efficacy.

Bouman HJ, Schömig E, van Werkum JW, Velder J, Hackeng CM, Hirschhäuser C, Waldmann C, Schmalz HG, ten Berg JM, Taubert D. Bouman HJ, et al. Nat Med. 2011 Jan;17(1):110-6. doi: 10.1038/nm.2281. Epub 2010 Dec 19. Nat Med. 2011. PMID: 21170047

4

Effect of gender difference on platelet reactivity.

Breet NJ, Sluman MA, van Berkel MA, van Werkum JW, Bouman HJ, Harmsze AM, Kelder JC, Zijlstra F, Hackeng CM, Ten Berg JM. Breet NJ, et al. Among authors: bouman hj. Neth Heart J. 2011 Nov;19(11):451-7. doi: 10.1007/s12471-011-0189-y. Neth Heart J. 2011. PMID: 21901505 Free PMC article.

5

Cytochrome P-450 polymorphisms and response to clopidogrel.

Taubert D, Bouman HJ, van Werkum JW. Taubert D, et al. Among authors: bouman hj. N Engl J Med. 2009 May 21;360(21):2249-50; author reply 2251. doi: 10.1056/NEJMc090391. N Engl J Med. 2009. PMID: 19458375 Free article. No abstract available.

6

Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients.

Vries MJ, Bouman HJ, Olie RH, Veenstra LF, Zwaveling S, Verhezen PW, Ten Cate-Hoek AJ, Ten Cate H, Henskens YM, van der Meijden PE. Vries MJ, et al. Among authors: bouman hj. Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):11-17. doi: 10.1093/ehjcvp/pvw026. Epub 2016 Sep 7. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 27609198

7

Platelet function tests for the monitoring of P2Y12 inhibitors.

Breet NJ, van Werkum JW, Bouman HJ, Ten Berg JM, Hackeng CM. Breet NJ, et al. Among authors: bouman hj. Expert Opin Med Diagn. 2010 May;4(3):251-65. doi: 10.1517/17530051003725139. Epub 2010 Apr 13. Expert Opin Med Diagn. 2010. PMID: 23488534

8

A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel.

van Werkum JW, Kleibeuker M, Postma S, Bouman HJ, Elsenberg EH, ten Berg JM, Hackeng CM. van Werkum JW, et al. Among authors: bouman hj. Int J Cardiol. 2010 Apr 1;140(1):123-6. doi: 10.1016/j.ijcard.2008.10.046. Epub 2008 Dec 16. Int J Cardiol. 2010. PMID: 19091430

9

A case-control study on platelet reactivity in patients with coronary stent thrombosis.

Bouman HJ, van Werkum JW, Breet NJ, ten Cate H, Hackeng CM, ten Berg JM. Bouman HJ, et al. J Thromb Haemost. 2011 May;9(5):909-16. doi: 10.1111/j.1538-7836.2011.04255.x. J Thromb Haemost. 2011. PMID: 21382172 Free article. Clinical Trial.

10

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.

Harmsze AM, van Werkum JW, Ten Berg JM, Zwart B, Bouman HJ, Breet NJ, van 't Hof AW, Ruven HJ, Hackeng CM, Klungel OH, de Boer A, Deneer VH. Harmsze AM, et al. Among authors: bouman hj. Eur Heart J. 2010 Dec;31(24):3046-53. doi: 10.1093/eurheartj/ehq321. Epub 2010 Sep 10. Eur Heart J. 2010. PMID: 20833683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results